Amygdala

The amygdala is a pair of almond-shaped neuron clusters sitting deep in the temporal lobes, one in each hemisphere. It forms a core node of the limbic system — the network of structures that processes emotion, memory, and motivated behaviour.

Though widely known as the brain's fear centre, that framing is too narrow. The amygdala assigns emotional weight, or salience, to incoming information: it helps the brain decide what deserves attention, what poses danger, and what is worth remembering. Its reach covers threat, reward, social signals, and novelty alike.

It is not a single uniform mass. Several internal nuclei serve distinct roles; the basolateral complex handles sensory input and associative learning, while the central nucleus connects outward to systems that coordinate the body's stress response.

How it works · its role

The amygdala receives sensory information through two routes: a fast, coarse pathway directly from the thalamus, and a slower, higher-resolution pathway routed through the cortex. This means a threat response can begin before conscious perception catches up — the body starts to react while the brain is still working out what it saw.

When the amygdala signals danger, it activates the hypothalamus and brainstem, triggering the release of stress hormones — epinephrine, cortisol — and shifting the body toward fight-or-flight. It simultaneously signals the hippocampus to consolidate the experience into long-term memory, which is why emotionally charged events are remembered more vividly than neutral ones.

The prefrontal cortex exerts a top-down regulatory influence on the amygdala, dampening its reactivity when a threat is assessed as non-urgent. The balance between prefrontal control and amygdala reactivity is considered central to anxiety, emotional regulation, and how trauma is processed and stored.

Relevance to substances & effects

Many substance classes converge on the amygdala, and their effects on it map closely onto the subjective experiences they produce.

MDMA markedly reduces amygdala reactivity to threatening or negative social stimuli. This effect is thought to underlie its empathogenic character — the lowering of social defensiveness and the increased sense of openness — and is part of the scientific rationale for research into its use alongside psychotherapy for trauma.

Classic psychedelics such as psilocybin and LSD alter how the amygdala responds to emotional faces and ambiguous social cues. Some research suggests they reduce threat-biased responses, which may relate to the shifts in perspective and emotional reappraisal reported by users and observed in therapeutic contexts.

Alcohol suppresses amygdala excitability at low-to-moderate doses, which is closely tied to its anxiolytic and socially disinhibiting effects. Benzodiazepines and other GABAergic drugs reduce amygdala activity through a related mechanism, producing reliable anxiolysis.

Cannabis has a more complex relationship with the amygdala. Low doses can dampen threat responses; higher doses, or use in anxiety-prone individuals, may increase amygdala reactivity — a likely contributor to cannabis-induced anxiety and paranoia. Stimulants tend to heighten amygdala sensitivity at elevated doses, which partly explains the anxiety, suspicion, or hypervigilance that can accompany heavy use.